Neuro-oncology is an interdisciplinary field of medicine dedicated to the study and treatment of brain tumors. It combines the advanced technology and knowledge of neurology, oncology, biomedical engineering, radiation therapy, and pharmacology to understand the effects of cancer on the brain. From diagnosis and treatment to long-term management of chronic conditions, neuro-oncology provides a comprehensive approach to treating brain tumors and other neurological conditions. The complexity of the central nervous system and its various components makes medical advancements in neuro-oncology critically important. Neuroscientists use sophisticated imaging modalities such as MRIs, PET scans and CT scans to diagnose tumors. They look for changes in tumor growth, size, and locations to inform treatment. In addition, neuro-oncologists may perform surgery, prescribe medications, utilize radiation therapy or chemotherapy, or perform palliative care for symptomatic relief of symptoms. Ultimately, the goal of neuro-oncology is to provide optimum therapeutic outcomes with minimal side effects, improve quality of life, and increase overall survival rates for those affected by brain tumors and other neurological conditions. Research is ongoing, and advancements in the understanding and treatment of these diseases is quickly evolving. Clinical trials, collaborations between medical professionals, and the use of emerging technologies are driving the innovation that is opening up new possibilities for those affected by brain tumors and other neurological diseases.
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signaling
Krishna Moorjani, Boston University, United States
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signaling
Abhay Murthy, Boston University, United States
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signalling
Ethan Liu, Boston University, United States